why is vstm stock down?
What happened. Shares of Verastem Oncology (NASDAQ:VSTM), a biotechnology company developing novel cancer therapies, are sliding after a highly anticipated data drop failed to impress investors. Shares of the biotech stock were down 42.9% as of 12:12 p.m. EDT on Monday.